Zacks.com on MSN

Synaptics (SYNA) Upgraded to Buy: Here's Why

Synaptics (SYNA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should Know

Immunocore (IMCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks Investment Research on MSN

Knot Offshore (KNOP) moves to strong buy: Rationale behind the upgrade

Knot Offshore (KNOP) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy).
Zacks Investment Research on MSN

Central Garden (CENT) upgraded to buy: What does it mean for the stock?

Central Garden (CENT) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...
eLife

Pallium-encoded valence-specific chemosensory amplification of eye-body coordination in larval zebrafish

Coordinated eye-body movements are essential for adaptive behavior, yet little is known about how multisensory input, particularly chemosensory cues, shapes this coordination. Using our enhanced ...
BMJ Open

Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) trial: a protocol for a pragmatic randomised study of diverticulitis treatment in the USA

Introduction Each year, millions of people experience recurrent diverticulitis episodes. Elective sigmoid colon resection reduces the risk of recurrence, but The American Society of Colon and Rectal ...